NASDAQ
Emmaus Life Sciences, Inc. (EMMA) has a fcf yield of -1.44% as of Friday, May 29, 2026. This represents a 98.84% increase compared to its 12-month average of -124.34%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.